Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

Phase 4

Completed

• Conditions: Blepharitis
• Interventions: Drug: Moxidectin 2 MG Oral Tablet; Drug: Placebo

• Registration Number: NCT06795165
• Lead Sponsor: Eye Research Foundation, Inc.

Brief Summary

A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2025-01-22
• Study First Submitted QC: 2025-01-22
• Study First Posted: 2025-01-27
• Study Start: 2025-02-02
• Primary Completion: 2025-04-28
• Study Completion: 2025-06-15
• Status Verified: 2025-08
• Last Update Submitted: 2025-08-06
• Last Update Posted: 2025-08-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Active blepharitis with collarettes

Exclusion Criteria

• Other clinically significant eye disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Active	Moxidectin 2 MG Oral Tablet	-
Active and Placebo	Moxidectin 2 MG Oral Tablet	-
Active and Placebo	Placebo	-
Placebo	Placebo	-

Primary Outcome Measures

Name	Time	Method
Collarette count	6 weels	Collarette Count

Trial Locations

Locations (1)

Eye Research Foundation, Inc.; 🇺🇸 Newport Beach, California, United States